Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Clinical and Experimental Immunology|October 13, 2007
Recent thymic emigrants in lymphoma patients with and without human immunodeficiency virus infection candidates for autologous peripheral stem cell transplantationC Pratesi, C Simonelli, S Zanussi, et al.
Haematologica|May 21, 1998
P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemiasD Damiani, M Michieli, A Ermacora, et al.
Vox Sanguinis|August 22, 2009
A new freezing and storage procedure improves safety and viability of haematopoietic stem cells and neutrophil engraftment: a single institution experienceL Abbruzzese, M Michieli, M Rupolo, et al.
Blood|July 1, 1997
Randomized trial of autologous filgrastim-primed bone marrow transplantation versus filgrastim-mobilized peripheral blood stem cell transplantation in lymphoma patientsD Damiani, R Fanin, F Silvestri, et al.
Annals of Hematology|September 12, 2002
Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemiaD Russo, P P Piccaluga, M Michieli, et al.
Vox Sanguinis|February 20, 2008
Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factorD Lorenzon, M Mazzucato, L Abbruzzese, et al.
Bone Marrow Transplantation|October 6, 2009
BU/melphalan and auto-SCT in AML patients in first CR: a 'Gruppo Italiano Trapianto di Midollo Osseo (GITMO)' retrospective studyR M Lemoli, A D'Addio, G Marotta, et al.
Leukemia & Lymphoma|June 28, 2001
Fludarabine, arabinosyl cytosine and idarubicin (FLAI) for remission induction in poor-risk acute myeloid leukemiaD Russo, G Pricolo, M Michieli, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 11, 2019
The German Hodgkin Study Group risk model is useful for Hodgkin lymphoma patients receiving radiotherapy after autologous stem cell transplantC Furlan, F Matrone, M Rupolo, et al.
Bone Marrow Transplantation|December 8, 2015
Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working PartyA Necchi, R Miceli, M Bregni, et al.
Pageof 5